Small cap News

A Brazilian appeals court overturned a suspension of Sigma Lithium's environmental licenses, letting it keep operating under its existing permits.

His warning followed a record Nasdaq close, while Stocktwits sentiment for SPY, QQQ and DIA was ‘extremely bullish.’

No plague case has been confirmed, and no government orders have been announced, but outbreak-linked stocks jumped anyway.

Twist’s Lilly agreement and involvement in Anthropic research highlight its role in building and testing AI-designed proteins.

Rocket, RegenXBio, Precision BioSciences, Kyverna and uniQure will present on Monday at a cell and gene-therapy conference.

Moderna will replace Warner Bros. Discovery in the Nasdaq-100 before markets open on Oct.9.

Fresh filings named Wayne Thorsen as AST SpaceMobile’s new commercial chief and disclosed a 200,000-RSU award.

Burry cited an 1880 account of reasoning before written language to challenge whether language models can achieve genuine understanding.

Vanguard’s six reporting entities collectively held 36.48 million shares after adding a net 2.43 million during Q2.

Secretary of War Pete Hegseth announced Autowarcom, focusing on autonomous warfare, drones, robotics and faster defense procurement.

IOVA surged 77% and IBRX gained 11%, bucking biotech’s decline, while SLS fell 14% and VNDA slipped 7%.

CEA Industries said that 5,799 votes were cast over five days across four shortlisted names for its name change.

Martin Shkreli, who said he was short KOD before the readout, questioned Zenkuda’s edge over Eylea and dismissed the added IL-6 targeting in KSI-501.

Costco's membership growth contrasted with steep drops at Stitch Fix and MGM Resorts.

Novo has 44 abstracts at EASD, including CagriSema analyses and Phase 2b Zenagamtide results.

The final rule is expected on Monday. The December proposal targeted 34.5 mpg by 2031, down from 50.4 mpg.

RKLB rose 14% this week after its 96th Electron launch, a bullish Cantor call, an ARK purchase and shareholder approval of its Iridium deal.

Five smaller stocks with market caps above $100 million beat MRNA’s monthly gain: INDP rose 249%, CYPH 124%, MNOV 85%, GRAL 58% and SRZN 53%.

CFO Tim Foote called QNX royalties “the star of the show” as BlackBerry’s $950 million backlog began converting into revenue.

Jason Calacanis bought small positions in WRD, PONY, LCID and RIVN, betting all four will be acquired within 24 months.

Burry also advised shorting equipment makers Applied Materials and Lam Research at current prices.

BlackBerry said the win adds more than $100 million to QNX’s estimated future royalty backlog.

Obesity specialist Lou Aronne said switching from a GLP-1 drug to a dual GLP-1/GIP drug could mean greater weight loss.

Hyperscale Data management said Bitcoin mining and AI infrastructure require different capital strategies and priorities.

Novo targets over $23 billion in risk-adjusted pipeline sales by 2035, excluding any contribution from future acquisitions.

Burry’s indirect AI bet is ERO, saying that data-center construction will intensify copper demand while new mines take 18 years to reach production.

Nio expects ES9 deliveries to reach 30,000 this week, less than four months after deliveries began.

Novo Nordisk (NVO) will hold its 2026 Capital Markets Day in London on Monday.

CRML recently reported a Tanbreez processing breakthrough and advanced its $835 million European Lithium merger to a shareholder vote.

Rocket Lab raised $1.944 billion for its $8 billion Iridium acquisition, while advancing Neutron hardware testing in Virginia.

Lucid’s European push comes amid Uber’s commitment to deploy at least 35,000 Lucid robotaxis equipped with Nuro tech.

Critical Metals detailed its Romania refinery plans, including $2.2 billion in projected annual revenue and $600 million from silica sales.

The rally followed a Nant Capital-led financing worth up to $22.3 million, with $11.3 million raised at the initial close.

Datavault AI’s new order expands its tokenization business across computing, sports rights and political data.

Seaport sees different trends across the restaurant stocks, with CAVA offering strong growth potential, while Wendy’s, Chipotle, Starbucks and McDonald’s face concerns around traffic, valuation and business performance.

Golden Dome’s space-based interceptor program reached “flight-ready hardware,” with an integrated demonstration targeted for 2028.

Alex Fink said Ratel’s combat-tested technology, existing contracts, and unmanned ground vehicles could enable larger drone swarm deployments.

Large-cap healthcare outperformed this week: XLV gained 1.4% through Tuesday, while XBI fell 1.4% and IBB declined 0.5%.

Shareholder votes set for Oct. 22 as the deal advances toward completion.

A William Li-founded Nio Capital fund acquired a 10.87% stake in robot-sensor maker Gongwang.

CEO Brian Lian said monthly VK2735 must preserve weight loss without restarting nausea, vomiting and other gastrointestinal effects.

J&J’s recent deals include the $3.05 billion Halda acquisition and $1 billion Firefly purchase, while Pfizer’s Innovent deal is worth up to $10.5 billion.

Investors reassessed opportunities across cybersecurity, defense materials, and identity protection.

Humana listed Counterpart Health among the vendors for its provider-performance and quality programs.

Dave & Buster’s missed second-quarter revenue estimates as well.

Burry recovered his initial investment “and then some” for charity, while retaining a sizable stake that is “deep into house’s money.”

Damodaran found that the S&P 500 moved about 0.5% when the 10-year yield changed by more than three basis points.

CEO Peter Beck blamed RKLB’s stock volatility on macro conditions, saying the business has improved across “every single metric.”

The BWET fund primarily tracks tanker rates on the Middle East Gulf-to-China route through the Strait of Hormuz.

Swarmer is planning to expand its defense technology footprint, and the stock has gained 13% year-to-date.